JP2011504485A5 - - Google Patents

Download PDF

Info

Publication number
JP2011504485A5
JP2011504485A5 JP2010534558A JP2010534558A JP2011504485A5 JP 2011504485 A5 JP2011504485 A5 JP 2011504485A5 JP 2010534558 A JP2010534558 A JP 2010534558A JP 2010534558 A JP2010534558 A JP 2010534558A JP 2011504485 A5 JP2011504485 A5 JP 2011504485A5
Authority
JP
Japan
Prior art keywords
substituted
unsubstituted
amine
fluorobut
fluoro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010534558A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011504485A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2008/003124 external-priority patent/WO2009066152A2/en
Publication of JP2011504485A publication Critical patent/JP2011504485A/ja
Publication of JP2011504485A5 publication Critical patent/JP2011504485A5/ja
Pending legal-status Critical Current

Links

JP2010534558A 2007-11-21 2008-11-19 Ｓｓａｏ／ｖａｐ−１のハロアリルアミン阻害剤およびその用途 Pending JP2011504485A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US98963407P 2007-11-21 2007-11-21
PCT/IB2008/003124 WO2009066152A2 (en) 2007-11-21 2008-11-19 Haloallylamine inhibitors of ssao/vap-1 and uses therefor

Publications (2)

Publication Number Publication Date
JP2011504485A JP2011504485A (ja) 2011-02-10
JP2011504485A5 true JP2011504485A5 (https=) 2011-05-26

Family

ID=40667907

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010534558A Pending JP2011504485A (ja) 2007-11-21 2008-11-19 Ｓｓａｏ／ｖａｐ−１のハロアリルアミン阻害剤およびその用途

Country Status (10)

Country Link
US (1) US8426587B2 (https=)
EP (1) EP2222160B1 (https=)
JP (1) JP2011504485A (https=)
CN (1) CN101917845A (https=)
AU (1) AU2008327615B2 (https=)
CA (1) CA2706465A1 (https=)
NZ (1) NZ585528A (https=)
SG (1) SG186008A1 (https=)
WO (1) WO2009066152A2 (https=)
ZA (1) ZA201003596B (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11724982B2 (en) 2014-10-10 2023-08-15 The Research Foundation For The State University Of New York Trifluoromethoxylation of arenes via intramolecular trifluoromethoxy group migration

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA112154C2 (uk) 2009-09-08 2016-08-10 Біоті Терапіс Корп. Застосування повністю людського анти-vap-1-антитіла для лікування фіброзних станів
FI20115234A0 (fi) 2011-03-08 2011-03-08 Biotie Therapies Corp Uusia pyridatsinoni- ja pyridoniyhdisteitä
EP2567959B1 (en) 2011-09-12 2014-04-16 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
EP3438087A1 (en) 2012-05-02 2019-02-06 Boehringer Ingelheim International GmbH Substituted 3-haloallylamine inhibitors of ssao and uses thereof
WO2014199171A1 (en) 2013-06-12 2014-12-18 Proximagen Limited New therapeutic uses of enzyme inhibitors
WO2015189534A1 (en) 2014-06-12 2015-12-17 Proximagen Limited Vap-1 inhibitors for treating muscular dystrophy
HK1256174A1 (zh) 2015-12-07 2019-09-13 Benevolentai Cambridge Limited 用於治疗疼痛的 vap-1 抑制剂
JP6849197B2 (ja) * 2016-02-12 2021-03-24 ファーマクシス リミテッド リジルオキシダーゼのインドールおよびアザインドールハロアリルアミン誘導体阻害剤およびその使用
WO2018027892A1 (en) 2016-08-12 2018-02-15 Eli Lilly And Company Amino pyrimidine ssao inhibitors
GB201617339D0 (en) 2016-10-12 2016-11-23 Lytix Biopharma As Therapeutic compounds
BR112019005930A2 (pt) 2016-10-19 2019-06-11 Boehringer Ingelheim Int combinações compreendendo um inibidor de ssao/vap-1 e um inibidor de sglt2, e usos das mesmas
WO2018148856A1 (en) 2017-02-14 2018-08-23 Eli Lilly And Company Diazaspirodecanyl-pyrimidine compounds useful as ssao inhibitors
ES2965478T3 (es) * 2017-03-01 2024-04-15 Boehringer Ingelheim Int Protodescarboxilación catalizada por metales de transición de derivados del ácido alfa-halo-acrílico
US20200069648A1 (en) * 2017-03-02 2020-03-05 Pharmaxis Ltd. Haloallylamine pyrazole derivative inhibitors of lysyl oxidases and uses thereof
US20200087248A1 (en) * 2017-04-28 2020-03-19 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Fluoroallylamine Derivative And Use Thereof
AU2018287777B2 (en) * 2017-06-20 2020-05-21 Shandong Danhong Pharmaceutical Co., Ltd. SSAO inhibitor
WO2019024924A1 (zh) * 2017-08-04 2019-02-07 广东东阳光药业有限公司 抑制ssao/vap-1的胺类化合物及其在医药上的应用
CN109810041B (zh) * 2017-11-21 2023-08-15 药捷安康(南京)科技股份有限公司 卤代烯丙基胺类ssao/vap-1抑制剂及其应用
CN109988109B (zh) * 2017-12-29 2020-12-29 广东东阳光药业有限公司 抑制ssao/vap-1的胺类化合物及其用途
KR20190110740A (ko) 2018-03-21 2019-10-01 주식회사유한양행 신규의 아릴 또는 헤테로아릴 트라이아졸론 유도체 또는 이의 염 및 이를 포함하는 약학 조성물
KR20190110736A (ko) 2018-03-21 2019-10-01 주식회사유한양행 신규의 트라이아졸론 유도체 또는 이의 염 및 이를 포함하는 약학 조성물
WO2020006177A1 (en) * 2018-06-29 2020-01-02 Blade Therapeutics, Inc. Vascular adhesion protein-1 (vap-1) modulators and therapeutic uses thereof
KR20200004036A (ko) * 2018-07-03 2020-01-13 주식회사유한양행 (e)-(2-(클로로메틸)-3-플루오로알릴)카바메이트 유도체의 제조방법
CN112533897B (zh) 2018-08-03 2023-07-14 法玛西斯有限公司 赖氨酰氧化酶的卤代烯丙胺砜衍生抑制剂及其用途
CN110938059A (zh) 2018-09-25 2020-03-31 上海轶诺药业有限公司 胺基脲敏感性胺氧化酶抑制剂制备及其应用
CN113164454A (zh) 2018-09-28 2021-07-23 奥克塞拉有限公司 Vap-1的抑制剂
MX2021003731A (es) 2018-09-28 2021-08-05 Acucela Inc Inhibidores de vap-1.
AU2019365213A1 (en) * 2018-10-24 2021-06-03 Metacrine, Inc. SSAO inhibitors and uses thereof
TWI835945B (zh) 2018-12-14 2024-03-21 南韓商柳韓洋行股份有限公司 3,3-二氟烯丙胺化物或其鹽及包含彼的醫藥組合物
TW202039486A (zh) 2018-12-14 2020-11-01 南韓商柳韓洋行股份有限公司 三唑并吡啶-3-酮化物或其鹽及包含彼之醫藥組合物
BR112021013429A2 (pt) 2019-01-11 2021-10-19 Nanjing Transthera Biosciences Co., Ltd. Composto, composição farmacêutica, e, uso do composto
WO2020233583A1 (zh) * 2019-05-20 2020-11-26 广东东阳光药业有限公司 抑制ssao/vap-1的异喹啉酮类化合物及其用途
AU2020317374A1 (en) * 2019-07-25 2022-02-03 Pharmaxis Ltd. Difluorohaloallylamine sulfone derivative inhibitors of lysyl oxidases, methods of preparation, and uses thereof
MX2022005199A (es) * 2019-10-29 2022-08-04 Eccogene Shanghai Co Ltd Inhibidores de ssao y uso de los mismos.
CN112876419A (zh) * 2019-11-29 2021-06-01 四川科伦博泰生物医药股份有限公司 烯丙胺衍生物及其制备方法和用途
US12578335B2 (en) * 2020-02-05 2026-03-17 Syntara Limited Bioprobes for lysyl oxidases and uses thereof
CN115916337B (zh) * 2020-06-26 2025-04-15 法玛西斯有限公司 卤代烯丙基胺双胺氧化酶抑制剂
JP2023539639A (ja) 2020-08-25 2023-09-15 イーライ リリー アンド カンパニー Ｓｓａｏ阻害剤の多形
CN114621189B (zh) * 2020-12-14 2024-01-02 上海拓界生物医药科技有限公司 一种内酰胺类衍生物及其用途
CN114621190B (zh) * 2020-12-14 2023-12-05 上海拓界生物医药科技有限公司 一种烯丙基胺类衍生物及其用途

Family Cites Families (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3710795A (en) * 1970-09-29 1973-01-16 Alza Corp Drug-delivery device with stretched, rate-controlling membrane
US4044126A (en) 1972-04-20 1977-08-23 Allen & Hanburys Limited Steroidal aerosol compositions and process for the preparation thereof
GB1429184A (en) 1972-04-20 1976-03-24 Allen & Hanburys Ltd Physically anti-inflammatory steroids for use in aerosols
USRE28819E (en) 1972-12-08 1976-05-18 Syntex (U.S.A.) Inc. Dialkylated glycol compositions and medicament preparations containing same
US4410545A (en) 1981-02-13 1983-10-18 Syntex (U.S.A.) Inc. Carbonate diester solutions of PGE-type compounds
US4328245A (en) * 1981-02-13 1982-05-04 Syntex (U.S.A.) Inc. Carbonate diester solutions of PGE-type compounds
US4358603A (en) 1981-04-16 1982-11-09 Syntex (U.S.A.) Inc. Acetal stabilized prostaglandin compositions
US4454158A (en) 1981-06-01 1984-06-12 Merrell Toraude Et Compagnie Allyl amine MAO inhibitors
DE3129826A1 (de) * 1981-07-29 1983-04-28 Grillo-Werke Ag, 4100 Duisburg Zinksalz der hydrolisierten tricarbonsaeure aus diels-alder-addukten von maleinsaeureanhydrid an undecylensaeure, verfahren zur herstellung derselben und ihre verwendung
US4409239A (en) 1982-01-21 1983-10-11 Syntex (U.S.A.) Inc. Propylene glycol diester solutions of PGE-type compounds
US4522811A (en) * 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US4650907A (en) * 1985-12-05 1987-03-17 Merrell Dow Pharmaceuticals Inc. Nonaromatic fluoroallylamine MAO inhibitors
DD246990A1 (de) * 1986-02-26 1987-06-24 Univ Leipzig Verfahren zur herstellung von gamma-chlorallylverbindungen aus polychloralkanen
FI890827A7 (fi) 1988-02-25 1989-08-26 Merrell Dow Pharma Lysyloxidas-inhibitorer.
US5585112A (en) * 1989-12-22 1996-12-17 Imarx Pharmaceutical Corp. Method of preparing gas and gaseous precursor-filled microspheres
IT1246382B (it) * 1990-04-17 1994-11-18 Eurand Int Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon
US5543390A (en) * 1990-11-01 1996-08-06 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University Covalent microparticle-drug conjugates for biological targeting
FI934857L (fi) 1992-03-04 1993-12-03 Akzo Nv Foerriktning av bindningspar in vivo
US6010715A (en) 1992-04-01 2000-01-04 Bertek, Inc. Transdermal patch incorporating a polymer film incorporated with an active agent
US6024975A (en) 1992-04-08 2000-02-15 Americare International Diagnostics, Inc. Method of transdermally administering high molecular weight drugs with a polymer skin enhancer
US6274552B1 (en) 1993-03-18 2001-08-14 Cytimmune Sciences, Inc. Composition and method for delivery of biologically-active factors
US5985307A (en) 1993-04-14 1999-11-16 Emory University Device and method for non-occlusive localized drug delivery
US5523092A (en) 1993-04-14 1996-06-04 Emory University Device for local drug delivery and methods for using the same
US6004534A (en) 1993-07-23 1999-12-21 Massachusetts Institute Of Technology Targeted polymerized liposomes for improved drug delivery
US5759542A (en) * 1994-08-05 1998-06-02 New England Deaconess Hospital Corporation Compositions and methods for the delivery of drugs by platelets for the treatment of cardiovascular and other diseases
US5733575A (en) * 1994-10-07 1998-03-31 Bpsi Holdings, Inc. Enteric film coating compositions, method of coating therewith, and coated forms
DE4438017C2 (de) * 1994-10-25 1996-10-31 Bosch Gmbh Robert Verfahren und Vorrichtung zur elektrischen Steuerung bzw. Regelung der Bremsanlage eines Fahrzeugs
US5660854A (en) 1994-11-28 1997-08-26 Haynes; Duncan H Drug releasing surgical implant or dressing material
US5565602A (en) * 1995-03-13 1996-10-15 Phillips Petroleum Company Production of thiolcarbamates
US5983134A (en) 1995-04-23 1999-11-09 Electromagnetic Bracing Systems Inc. Electrophoretic cuff apparatus drug delivery system
US6316652B1 (en) * 1995-06-06 2001-11-13 Kosta Steliou Drug mitochondrial targeting agents
US6167301A (en) 1995-08-29 2000-12-26 Flower; Ronald J. Iontophoretic drug delivery device having high-efficiency DC-to-DC energy conversion circuit
US6039975A (en) 1995-10-17 2000-03-21 Hoffman-La Roche Inc. Colon targeted delivery system
TW345603B (en) * 1996-05-29 1998-11-21 Gmundner Fertigteile Gmbh A noise control device for tracks
US5985317A (en) * 1996-09-06 1999-11-16 Theratech, Inc. Pressure sensitive adhesive matrix patches for transdermal delivery of salts of pharmaceutical agents
HUP0000116A3 (en) * 1996-10-01 2000-08-28 Stanford Res Inst Int Taste-masked microcapsule compositions and methods of manufacture
US6131570A (en) * 1998-06-30 2000-10-17 Aradigm Corporation Temperature controlling device for aerosol drug delivery
JP3333101B2 (ja) * 1996-11-27 2002-10-07 シャープ株式会社 光結合器の製造方法
US5860674A (en) * 1997-01-31 1999-01-19 Robert Bosch Corporation AOS fan modulation systems
US5860957A (en) 1997-02-07 1999-01-19 Sarcos, Inc. Multipathway electronically-controlled drug delivery system
US6120751A (en) 1997-03-21 2000-09-19 Imarx Pharmaceutical Corp. Charged lipids and uses for the same
US6060082A (en) 1997-04-18 2000-05-09 Massachusetts Institute Of Technology Polymerized liposomes targeted to M cells and useful for oral or mucosal drug delivery
US6800744B1 (en) * 1997-07-02 2004-10-05 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
US5948433A (en) 1997-08-21 1999-09-07 Bertek, Inc. Transdermal patch
WO1999021537A1 (fr) 1997-10-28 1999-05-06 Bando Chemical Industries, Ltd. Feuille de timbre cutane et procede de production d'une feuille de base pour timbre
US6048736A (en) * 1998-04-29 2000-04-11 Kosak; Kenneth M. Cyclodextrin polymers for carrying and releasing drugs
US6256633B1 (en) * 1998-06-25 2001-07-03 U.S. Philips Corporation Context-based and user-profile driven information retrieval
US6271359B1 (en) 1999-04-14 2001-08-07 Musc Foundation For Research Development Tissue-specific and pathogen-specific toxic agents and ribozymes
US6256533B1 (en) 1999-06-09 2001-07-03 The Procter & Gamble Company Apparatus and method for using an intracutaneous microneedle array
US6261595B1 (en) 2000-02-29 2001-07-17 Zars, Inc. Transdermal drug patch with attached pocket for controlled heating device
JP2004502682A (ja) * 2000-07-05 2004-01-29 バイオティ　セラピーズ　コーポレイション 銅含有アミン・オキシダーゼの阻害剤
GB2408071B (en) 2002-08-17 2005-10-19 Siemens Magnet Technology Ltd Pressure relief valve for a helium gas compressor
AU2003259965A1 (en) 2002-08-20 2004-03-11 Neurogenetics, Inc. Methods and compositions for modulating amyloid beta
JP4758337B2 (ja) * 2003-03-31 2011-08-24 株式会社アールテック・ウエノ 血管透過性亢進疾患を治療する方法
ES2335769T3 (es) * 2003-05-26 2010-04-05 Biotie Therapies Corp. Vap-1 cristalina y sus usos.
KR20060135781A (ko) * 2004-02-25 2006-12-29 라 졸라 파마슈티칼 컴파니 질병의 치료를 위한 아민 및 아미드
CN1921841A (zh) * 2004-02-25 2007-02-28 拉卓拉药物公司 用于治疗疾病的胺和酰胺类化合物
ITMI20041154A1 (it) * 2004-06-09 2004-09-09 Italiana Sint Spa Procedimento di sintesi di terbinafina e suoi derivati
WO2006094201A2 (en) 2005-03-02 2006-09-08 La Jolla Pharmaceutical Company Semicarbazide-sensitive amide oxidase inhibitors
US20070021365A1 (en) 2005-06-21 2007-01-25 The Board Of Trustees Of The Leland Stanford Junior University Inhibition of Lysyl oxidase for treating tumor growth and diagnostics relating thereto
US9161922B2 (en) * 2005-07-01 2015-10-20 Case Western Reserve University Amine oxidase inhibitors
US7540564B2 (en) 2006-03-30 2009-06-02 Esther Gokhale Ergonomic systems and devices
WO2007120528A2 (en) * 2006-03-31 2007-10-25 La Jolla Pharmaceutical Company Inhibitors of semicarbazide-sensitive amine oxidase (ssao) and vap-1 mediated adhesion useful for treatment and prevention of diseases

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11724982B2 (en) 2014-10-10 2023-08-15 The Research Foundation For The State University Of New York Trifluoromethoxylation of arenes via intramolecular trifluoromethoxy group migration

Similar Documents

Publication Publication Date Title
JP2011504485A5 (https=)
JP2007502806A5 (https=)
JP2006501295A5 (https=)
JP2006526630A5 (https=)
JP2005522438A5 (https=)
JP2010522197A5 (https=)
SK18002000A3 (sk) Použitie zlúčenín na zvýšenie aktivity pyruvát-dehydrogenázy, zlúčeniny, spôsob ich prípravy a farmaceutická kompozícia, ktorá ich obsahuje
NZ614305A (en) Sulfonamide derivatives as bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
JP2005508349A5 (https=)
JP2012515724A5 (https=)
JPWO2023195529A5 (https=)
JP2008542365A5 (https=)
US7718646B2 (en) Cyclohexyl(alkyl)propanolamines, preparation method and pharmaceutical compositions containing same
JP2010504321A5 (https=)
JP2008519783A5 (https=)
CN1422244A (zh) 制备胺衍生物的方法
JP2005518363A5 (https=)
CA2468311A1 (en) Benzothiazole derivatives
JP2005508382A5 (https=)
CN1268938A (zh) 氨基环烷烃化合物
CN1735603A (zh) 苯并吗啉衍生物
CN1404468A (zh) 苯基杂烷基胺衍生物的新用途
JP4852230B2 (ja) プロパノールアミノメチルテトラリン、それらの製造方法およびそれらを含む医薬組成物
PT1375785E (pt) Fechadura para portas e semelhantes
JP2008512465A5 (https=)